MARK2 Antikörper
Kurzübersicht für MARK2 Antikörper (ABIN646684)
Target
Alle MARK2 Antikörper anzeigenReaktivität
Wirt
Konjugat
Applikation
-
-
Spezifität
- Peptide ELISA: Antibody detection limit dilution 1:16,000. Western Blot: Approx 70kDa band observed in Human Brain (Cerebellum) lysates (calculated MW of 77.6kDa according to NP_004945.3). Recommended concentration: 0.3-1µg/ml.
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus), Rind (Kuh)
-
Produktmerkmale
- Goat Anti-MARK2 / PAR-1
-
Immunogen
- Peptide with sequence C-QNGKDSTAPQR, from the internal region of the protein sequence according to NP_001034557.1, NP_001034558.1, NP_004945.3, NP_059672.2 PresentationSupplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
-
-
-
Kommentare
-
This antibody recognizes the reported isoforms (NP_001034557.1, NP_004945.3)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- -20 °C
-
-
- MARK2 (MAP/microtubule Affinity-Regulating Kinase 2 (MARK2))
-
Andere Bezeichnung
- MARK2 / PAR-1
-
Hintergrund
- Synonyms: MARK2, MAP/microtubule affinity-regulating kinase 2, EMK1, MGC99619, PAR-1, ELKL motif kinase, ELKL motif kinase 1, protein-serine/threonine kinase, serine/threonine kinase
-
Gen-ID
- 2011
-
NCBI Accession
- NP_001034557
-
Pathways
- SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-